Design and Synthesis of Novel USP1 Inhibitors for Therapeutic Applications.

The present invention details novel inhibitors of ubiquitin-specific protease 1 (USP1) and their pharmaceutically acceptable forms, compositions, and methods of use. These compounds demonstrate therapeutic potential for the treatment and prevention of USP1-related diseases, either as single agents or in combination with additional therapeutic agents.